Last update Feb. 7, 2022

R03DA01

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Bronchodilator derived from theophylline and with less activity than this. Indicated in the treatment of asthma. Oral administration every 6 hours or intramuscularly.

It is excreted in breast milk in an amount that could be clinically significant, since the infant can receive, through breast milk, up to a quarter of the usual pediatric dose. (Jarboe 1981)

American Academy of Pediatrics: medication usually compatible with breastfeeding.(AAP 2001)

Monitor the appearance of irritability or insomnia in the infant.

Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity.

Alternatives

  • Albuterol (Safe substance and/or breastfeeding is the best option.)
  • Aminophylline (Safe substance and/or breastfeeding is the best option.)
  • Terbutaline Sulfate (Safe substance and/or breastfeeding is the best option.)
  • Theophylline (Safe substance and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

R03DA01 is Diprophylline in ATC Code/s.

Is written in other languages:

R03DA01 is also known as

Group

R03DA01 belongs to this group or family:

Tradenames

Main tradenames from several countries containing R03DA01 in its composition:

List of 7 tradenames

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 100 %
Molecular weight 254 daltons
Protein Binding 84 %
VD 0.5 l/Kg
pKa 13.91 -
Tmax 2 - 4 hours
T½ 3.2 ± 0.76 hours
M/P ratio 2.1 -
Theoretical Dose 2. 4 - 3.64 mg/Kg/d
Relative Dose 48 - 72 %
Ped.Relat.Dose 17.1 - 26 %

References

  1. AAP - American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001 Sep;108(3):776-89. Abstract Full text (link to original source) Full text (in our servers)
  2. Stablein JJ, Samaan SS, Bukantz SC, Lockey RF. Pharmacokinetics and bioavailability of three dyphylline preparations. Eur J Clin Pharmacol. 1983;25(2):281-3. Abstract
  3. Jarboe CH, Cook LN, Malesic I, Fleischaker J. Dyphylline elimination kinetics in lactating women: blood to milk transfer. J Clin Pharmacol. 1981 Oct;21(10):405-10. Abstract

Total visits

814

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM